In 2017, Liu et al. revealed hypermethylation in the promoter region of BMPR2 in familial PAH patients, suggesting that BMPR2 expression may be epigenetically suppressed in PAH [45]. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.